Insights

Gene Therapy Leadership Passage Bio is a genetic medicine company focusing on cutting-edge therapeutics for central nervous system disorders. With a deep pipeline targeting diseases like GM1 gangliosidosis and Krabbe disease, there are substantial sales opportunities in providing transformative therapies for these devastating conditions.

Recent Expansion Passage Bio's new laboratory at the Princeton West Innovation Campus in New Jersey signifies an evolution in biotech innovation. This expansion offers potential sales prospects in supplying advanced equipment, technologies, and services to support the company's research and development efforts.

Financial Investment With an impressive total funding of $154M and revenues between $10-50M, Passage Bio presents opportunities for financial service providers, investment firms, and strategic partners looking to be part of the growth and success of a promising genetics medicine company.

Strategic Hires Passage Bio's strategic hiring, including bringing on King as CFO and appointing Dolan Sondhi to key committees, indicates a focus on strengthening the leadership team. Sales professionals could explore partnerships providing HR solutions, executive training, or specialized consulting services to support the company's growth trajectory.

Clinical Trial Progress The release of positive interim clinical data from Imagine-1 study and the upliFT-D trial demonstrates Passage Bio's advancement in gene therapy. Sales opportunities exist for suppliers of clinical trial services, biomarker analysis tools, and drug development technologies aiming to collaborate with a forward-looking biotech company.

Passage Bio Tech Stack

Passage Bio uses 8 technology products and services including Backbone.js, RequireJS, Mustache, and more. Explore Passage Bio's tech stack below.

  • Backbone.js
    Javascript Frameworks
  • RequireJS
    Javascript Frameworks
  • Mustache
    Javascript Frameworks
  • Windows Server
    Operating Systems
  • New Relic
    Real User Monitoring
  • FedEx
    Transportation And Fleet Management
  • UPS
    Transportation And Fleet Management
  • Nginx
    Web Servers

Media & News

Passage Bio's Email Address Formats

Passage Bio uses at least 1 format(s):
Passage Bio Email FormatsExamplePercentage
flast@passagebio.comJDoe@passagebio.com
49%
first.last@passagebio.comJohn.Doe@passagebio.com
1%
last@passagebio.comDoe@passagebio.com
1%
flast@passagebio.comJDoe@passagebio.com
49%

Frequently Asked Questions

Where is Passage Bio's headquarters located?

Minus sign iconPlus sign icon
Passage Bio's main headquarters is located at 2005 Market Street 39th Floor Philadelphia, Pennsylvania 19103 US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Passage Bio's stock symbol?

Minus sign iconPlus sign icon
Passage Bio is a publicly traded company; the company's stock symbol is PASG.

What is Passage Bio's official website and social media links?

Minus sign iconPlus sign icon
Passage Bio's official website is passagebio.com and has social profiles on LinkedIn.

How much revenue does Passage Bio generate?

Minus sign iconPlus sign icon
As of May 2024, Passage Bio's annual revenue reached $35M.

What is Passage Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Passage Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Passage Bio have currently?

Minus sign iconPlus sign icon
As of May 2024, Passage Bio has approximately 83 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: W. C.Chief Executive Officer And President: B. G.Chief Technical Officer: A. F.. Explore Passage Bio's employee directory with LeadIQ.

What industry does Passage Bio belong to?

Minus sign iconPlus sign icon
Passage Bio operates in the Biotechnology Research industry.

What technology does Passage Bio use?

Minus sign iconPlus sign icon
Passage Bio's tech stack includes Backbone.jsRequireJSMustacheWindows ServerNew RelicFedExUPSNginx.

What is Passage Bio's email format?

Minus sign iconPlus sign icon
Passage Bio's email format typically follows the pattern of . Find more Passage Bio email formats with LeadIQ.

How much funding has Passage Bio raised to date?

Minus sign iconPlus sign icon
As of May 2024, Passage Bio has raised $154M in funding. The last funding round occurred on Jan 21, 2021.

When was Passage Bio founded?

Minus sign iconPlus sign icon
Passage Bio was founded in 2017.
Passage Bio

Passage Bio

Biotechnology ResearchPennsylvania, United States51-200 Employees

We are a genetics medicine company based in Philadelphia, PA, a city with a rich history of scientific discovery and medical advancement. As a leading developer of cutting-edge therapeutics for disorders of the central nervous system (CNS), we are proud to be a part of this dynamic research community. We are also excited about our new laboratory at the Princeton West Innovation Campus in Hopewell, New Jersey, which will help us evolve the standard for biotech innovation and development.

At Passage Bio, we have a bold vision to fulfill the promise of gene therapy and a differentiated approach to gene therapy development through our collaboration with University of Pennsylvania's Gene Therapy Program and Orphan Disease Center.

Our deep pipeline of optimized gene therapies for CNS disorders includes lead programs focused on the following devastating diseases:

GM1 gangliosidosis
Krabbe disease
Frontotemporal dementia 

Section iconCompany Overview

Headquarters
2005 Market Street 39th Floor Philadelphia, Pennsylvania 19103 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PASG
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $154M

    Passage Bio has raised a total of $154M of funding over 3 rounds. Their latest funding round was raised on Jan 21, 2021.

  • $10M$50M

    Passage Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $154M

    Passage Bio has raised a total of $154M of funding over 3 rounds. Their latest funding round was raised on Jan 21, 2021.

  • $10M$50M

    Passage Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.